Safety And Clinical Activity Of Gene-Engineered T-Cell Therapy Targeting Hpv-16 E7 For Epithelial Cancers.

JOURNAL OF CLINICAL ONCOLOGY(2020)

引用 18|浏览58
暂无评分
摘要
101Background: Genetically engineered T-cell therapy has shown remarkable clinical activity in hematologic malignancies. It is not known if this type of treatment can be applied effectively to epit...
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要